Mark Trusheim
- Economics and Econometrics top 5%
- Molecular Biology
- Physiology
- Immunology
- Statistics and Probability top 5%
- Co-authors
- Ernst R. BerndtFrank L. DouglasRobert L. JacksonCasey QuinnColin M. YoungPeter B. BachWilliam M. CassidyJonathan C. Thomas
- Topics
- Health Systems, Economic Evaluations, Quality of Life (22 papers)Pharmaceutical Economics and Policy (22 papers)Biomedical Ethics and Regulation (9 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Mark Trusheim
39 papers receiving 880 citations
Peers
Comparison fields: 5 of 145
- Economics and Econometrics 319
- Molecular Biology 182
- Physiology 123
- Immunology 119
- Statistics and Probability 96
Countries citing papers authored by Mark Trusheim
This map shows the geographic impact of Mark Trusheim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Trusheim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Trusheim more than expected).
Fields of papers citing papers by Mark Trusheim
This network shows the impact of papers produced by Mark Trusheim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Trusheim. The network helps show where Mark Trusheim may publish in the future.
Co-authorship network of co-authors of Mark Trusheim
This figure shows the co-authorship network connecting the top 25 collaborators of Mark Trusheim. A scholar is included among the top collaborators of Mark Trusheim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Trusheim. Mark Trusheim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 9 | |
| 4 | 2 | |
| 5 | 33 | |
| 6 | 29 | |
| 7 | 51 | |
| 8 | 8 | |
| 9 | Investigating investment in biopharmaceutical R&D | 3 |
| 10 | 15 | |
| 11 | 57 | |
| 12 | 11 | |
| 13 | 8 | |
| 14 | 12 | |
| 15 | 7 | |
| 16 | The Segmentation of Therapeutic Populations in Oncology | 6 |
| 17 | 13 | |
| 18 | 14 | |
| 19 | 29 | |
| 20 | 28 |
About Mark Trusheim
Mark Trusheim is a scholar working on Economics and Econometrics, Statistics and Probability and Management of Technology and Innovation, having authored 40 papers that have together received 943 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (22 papers), Pharmaceutical Economics and Policy (22 papers) and Biomedical Ethics and Regulation (9 papers). The work is most often cited by research in Statistics and Probability (96 citations), Economics and Econometrics (319 citations) and Pharmacology (66 citations). Mark Trusheim has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Ernst R. Berndt, Frank L. Douglas, Robert L. Jackson, Casey Quinn, Colin M. Young, Peter B. Bach, William M. Cassidy, Jonathan C. Thomas, Murray Aitken and Gigi Hirsch. Their work appears in journals such as New England Journal of Medicine, Journal of the American Chemical Society and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.